Article in Pathogens (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed.
Pathogens (Basel, Switzerland) · 2026
Article
4 · The record
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors.
Verónica Ivonne Hernández-RamírezDepartamento de Infectómica y Patogénesis Molecular, CINVESTAV, Av. IPN No. 2508, Col. San Pedro Zacatenco, México City 07360, Mexico.
Audifás-Salvador Matus-MezaDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 69198, USA.ORCID 0000-0002-2987-7119
Norma OviedoUnidad de Investigación Médica en Inmunología e Infectología, Centro Médico Nacional La Raza, IMSS, Av. Jacarandas S/N, La Raza, Azcapotzalco, México City 02990, Mexico.ORCID 0000-0002-2359-5751
Marco Antonio Magos-CastroDepartamento de Genética y Biología Molecular, CINVESTAV, Av. IPN No. 2508, Col. San Pedro Zacatenco, México City 07360, Mexico.
Carlos Osorio-TrujilloDepartamento de Infectómica y Patogénesis Molecular, CINVESTAV, Av. IPN No. 2508, Col. San Pedro Zacatenco, México City 07360, Mexico.
Lizbeth Salazar-VillatoroDepartamento de Infectómica y Patogénesis Molecular, CINVESTAV, Av. IPN No. 2508, Col. San Pedro Zacatenco, México City 07360, Mexico.ORCID 0000-0003-4172-7153
Luis Alejandro Constantino-JonapaUnidad de Investigación UNAM-INC, División de Investigación, Facultad de Medicina, UNAM, Instituto Nacional de Cardiología Ignacio Chávez, México City 14080, Mexico.ORCID 0000-0003-0773-2581
Patricia Talamás-RohanaDepartamento de Infectómica y Patogénesis Molecular, CINVESTAV, Av. IPN No. 2508, Col. San Pedro Zacatenco, México City 07360, Mexico.ORCID 0000-0002-5085-814X
Funding
CONAHCYT A1-S-15223
6 · The paper itself
Abstract
Recently, we published that the monoclonal antibody (D12 mAb) recognizes gp63 of
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Exploration of the Binding Site of Arachidonic Acid in gp63 of · full record | OpenQuestion